Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
1(17%)
Results Posted
33%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_1
1
17%
Ph early_phase_1
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
60.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (33.3%)
Phase 11 (33.3%)
N/A1 (33.3%)

Trials by Status

recruiting117%
completed350%
terminated233%

Recent Activity

1 active trials
Showing 5 of 6
recruiting

Longitudinal Early-onset Alzheimer's Disease Study Protocol

NCT03507257
completedphase_1

Imaging Inflammation in Alzheimer's Disease With 11C-ER176

NCT03744312
terminatedearly_phase_1

Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT

NCT04105634
completed

Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease

NCT04510168
terminatednot_applicable

Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study

NCT02362880
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03507257

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Recruiting
NCT03744312Phase 1

Imaging Inflammation in Alzheimer's Disease With 11C-ER176

Completed
NCT04105634Early Phase 1

Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT

Terminated
NCT04510168

Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease

Completed
NCT02362880Not Applicable

Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study

Terminated
NCT01297114

Imaging of Cognition, Learning, and Memory in Aging

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6